Lv7
3400 积分 2024-05-26 加入
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors
7小时前
已完结
Unlocking the anti-aging potential: In silico analysis of astaxanthin, curcumin, quercetin, and resveratrol in modulating skin aging pathways
1个月前
已关闭
Unlocking the anti-aging potential: In silico analysis of astaxanthin, curcumin, quercetin, and resveratrol in modulating skin aging pathways
1个月前
已关闭
Psoriasis modulates inflammatory bowel disease risk and intestinal epithelium lipid metabolism via IL-1β-producing macrophages
1个月前
已完结
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
1个月前
已完结
A Ligand‐Based Approach to the Discovery of Lead‐Like Potassium Channel K V 1.3 Inhibitors
1个月前
已完结
Deucravacitinib for the Treatment of Psoriatic Disease
2个月前
已完结
Computational insights of deucravacitinib’s selectivity for TYK2 pseudokinase vs. JAK kinase domain via molecular modeling studies
2个月前
已完结
Computational insights of deucravacitinib’s selectivity for TYK2 pseudokinase vs. JAK kinase domain via molecular modeling studies
2个月前
已完结
Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors
3个月前
已完结
皖公网安备34019202002308
